(1997). A comparison of lowmolecular-weight heparin with unfractionated heparin for acute pulmonary embolism: the THESEE (Tinzaparine ou Heparine Standard: Evaluations dans l’Embolie Pulmonaire) Study Group..
(1991). A populationbased perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism.
(2006). Clinical characteristics of acute pulmonary thromboembolism in Korea.
Clinical study of pulmonary thromboembolism.
Derivation and validation of a prognostic model for pulmonary embolism.
Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost
Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy.
Pulmonary embolism as a cause of cardiac arrest: presentation and outcome.
(2003). Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome. Thromb Haemost 2004;91:1232-1236. Choi WH, et al. Use of PESI to predict prognosis of pulmonary embolism